Department of Pediatrics/Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Inflamm Bowel Dis. 2012 Feb;18(2):323-32. doi: 10.1002/ibd.21779.
Activated effector T cells contribute to tissue injury observed in inflammatory bowel disease. T cells are recruited to effector sites after activation in peripheral lymph nodes directs expression of tissue-specific homing receptors. One such mechanism for effector T cell recruitment employs activation-induced fucosylation of P-selectin glycoprotein ligand (PSGL)-1 that mediates binding to endothelial P-selectin. Here we examine the differential role of PSGL-1 in recruiting effector T-cell subsets in colitis.
C57BL/6 wildtype and PSGL-1 mice received 2.5% dextran sodium sulfate (DSS) for 6 days and were euthanized 7 and 14 days after the initiation of DSS. Disease activity was monitored throughout. Histologic colitis scores, colonic CD4+ accumulation, and cytokine production were assessed at days 7 and 14. Recruitment of T-helper (Th) subsets was assessed by enumerating adoptively transferred Th1 or Th17 CD4+ cells 2 days after transfer to DSS-treated mice.
DSS colitis increases CD4+ T cells in colonic tissue and induces Th1 (interferon gamma [IFN-γ], tumor necrosis factor [TNF]) and Th17 (interleukin [IL]-17, IL-22) cytokines. Loss of PSGL-1 attenuates DSS colitis, decreases colonic CD4+ T cell numbers, and reduces both Th1 and Th17 cytokine production. Colitis increases recruitment of Th1 (19-fold) and Th17 (2.5-fold) cells. PSGL-1 deficiency in transferred T cells abrogates colonic recruitment of Th1 cells in DSS colitis, whereas Th17 recruitment is unaffected.
PSGL-1 selectively controls Th1 recruitment in colitis. Whereas Th17 recruitment is independent of PSGL-1, generation of colonic Th17 cytokine requires initial Th1 recruitment. Therefore, attenuating PSGL-1 binding may prevent colonic recruitment of disease-causing Th1 cells that promote local Th17 generation.
活化的效应 T 细胞有助于炎症性肠病中观察到的组织损伤。T 细胞在周围淋巴结中被激活后被募集到效应部位,这促使组织特异性归巢受体的表达。一种这样的效应 T 细胞募集机制是通过激活诱导的 P-选择素糖蛋白配体(PSGL)-1 的岩藻糖基化来实现的,该机制介导与内皮细胞 P-选择素的结合。在这里,我们研究了 PSGL-1 在招募结肠炎中效应 T 细胞亚群中的差异作用。
C57BL/6 野生型和 PSGL-1 小鼠接受 2.5%葡聚糖硫酸钠(DSS)处理 6 天,并在 DSS 开始后 7 和 14 天处死。整个过程中监测疾病活动。在第 7 和 14 天评估组织学结肠炎评分、结肠 CD4+积累和细胞因子产生。通过在转移到 DSS 处理的小鼠后 2 天计数过继转移的 Th1 或 Th17 CD4+细胞来评估 Th 亚群的募集。
DSS 结肠炎增加结肠组织中的 CD4+T 细胞,并诱导 Th1(干扰素γ[IFN-γ],肿瘤坏死因子[TNF])和 Th17(白细胞介素[IL]-17,IL-22)细胞因子。PSGL-1 的缺失减轻了 DSS 结肠炎,减少了结肠 CD4+T 细胞数量,并减少了 Th1 和 Th17 细胞因子的产生。结肠炎增加了 Th1(19 倍)和 Th17(2.5 倍)细胞的募集。在 DSS 结肠炎中,转移 T 细胞中 PSGL-1 的缺失消除了 Th1 细胞在结肠中的募集,而 Th17 细胞的募集不受影响。
PSGL-1 选择性控制结肠炎中的 Th1 募集。虽然 Th17 募集不依赖于 PSGL-1,但结肠 Th17 细胞因子的产生需要初始 Th1 募集。因此,抑制 PSGL-1 结合可能会阻止引起疾病的 Th1 细胞在结肠中的募集,从而促进局部 Th17 的产生。